This site may require a log-in in the near future. We are constantly being swamped by AI agents. If they continue to take down the site, we will be changing to requiring logins to access any item.

🍽️ meclofenamic acid sodium salt monohydrate,(prescription)

AI Engines For more Details: Perplexity  Kagi Labs  You 

  1. Pain Relief: Meclofenamic acid is effective in reducing pain associated with various conditions, including menstrual cramps, dental pain, musculoskeletal injuries, and postoperative pain.

  2. Inflammation Reduction: It helps to decrease inflammation by inhibiting the production of prostaglandins, which are chemicals in the body that contribute to pain and inflammation.

  3. Rheumatic Conditions: Meclofenamic acid is commonly used to manage symptoms of rheumatic conditions such as rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis. It can help reduce joint pain, stiffness, and swelling.

  4. Primary Dysmenorrhea: This medication is often prescribed for the treatment of primary dysmenorrhea (menstrual pain) in women. It can alleviate menstrual cramps and discomfort.

  5. Fever Reduction: Meclofenamic acid can help lower fever by acting on the hypothalamus, the part of the brain that regulates body temperature.

  6. Dosage and Administration: The dosage of meclofenamic acid sodium salt monohydrate may vary depending on the severity of the condition being treated and the individual's response to the medication. It is typically taken orally in the form of tablets or capsules, with or without food. It's important to follow the dosage instructions provided by the healthcare provider.

  7. Side Effects: Common side effects of meclofenamic acid may include gastrointestinal symptoms such as stomach pain, nausea, vomiting, diarrhea, and indigestion. Long-term use or high doses of NSAIDs like meclofenamic acid can increase the risk of gastrointestinal ulcers and bleeding. Other potential side effects include headache, dizziness, drowsiness, rash, and elevated blood pressure.

  8. Cardiovascular Risk: NSAIDs, including meclofenamic acid, may increase the risk of cardiovascular events such as heart attack or stroke, especially in individuals with pre-existing cardiovascular disease or risk factors.

  9. Renal Effects: Prolonged use of meclofenamic acid can affect kidney function and may lead to fluid retention, edema, and decreased urine output. Individuals with impaired renal function or dehydration may be at higher risk of experiencing these effects.

  10. Allergic Reactions: Some individuals may experience allergic reactions to meclofenamic acid, characterized by symptoms such as hives, swelling of the face or throat, difficulty breathing, and anaphylaxis. If any signs of an allergic reaction occur, medical attention should be sought immediately.

  11. Contraindications: Meclofenamic acid is contraindicated in individuals with a history of hypersensitivity to NSAIDs, peptic ulcer disease, gastrointestinal bleeding, severe heart failure, and severe renal impairment. It should be used with caution in patients with asthma, hypertension, or liver dysfunction.

  12. Drug Interactions: Meclofenamic acid may interact with other medications, including anticoagulants, antiplatelet drugs, selective serotonin reuptake inhibitors (SSRIs), and certain diuretics. Patients should inform their healthcare provider about all medications and supplements they are taking to avoid potential interactions.

;

Check for interactions on Supp.AI   |   📚 PubMed Citations

⚗️ Compensation for antibiotic usage

Data Contradictions — Limits of Certainity

Impacted of meclofenamic acid sodium salt monohydrate,(prescription) On Probiotics

Rank Probiotic Impact
genus Bifidobacterium Reduces
species Bacteroides uniformis Reduces
species Bifidobacterium adolescentis Reduces
species Escherichia coli Reduces
species Lacticaseibacillus paracasei Reduces
species Parabacteroides distasonis Reduces

Bacteria Impacted by meclofenamic acid sodium salt monohydrate,(prescription)

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

🧙?

📓 Direct Citations 👪👶 Indirect Citations Taxonomy Rank Effect
0 1 Parabacteroides genus Decreases
0 1 Fusobacterium genus Decreases
0 1 Odoribacter genus Decreases
0 1 Bacteroides genus Decreases
0 1 Clostridioides genus Decreases
0 1 Streptococcus genus Decreases
0 1 Lacrimispora genus Decreases
0 1 Clostridium genus Decreases
0 1 Segatella genus Decreases
0 1 Coprococcus genus Decreases
0 1 Escherichia genus Decreases
0 2 Phocaeicola genus Decreases
0 1 Mediterraneibacter genus Decreases
0 1 Lacticaseibacillus genus Decreases
0 1 Thomasclavelia genus Decreases
0 1 Bifidobacterium genus Decreases
0 1 Ruminococcus genus Decreases
0 1 Bilophila genus Decreases
0 1 Blautia genus Decreases
0 1 Dorea genus Decreases
0 1 Clostridium perfringens A no rank Decreases
0 1 Clostridium perfringens B no rank Decreases
0 1 Clostridium perfringens C no rank Decreases
0 1 Clostridium perfringens CPE no rank Decreases
0 1 Clostridium perfringens D no rank Decreases
0 1 Clostridium perfringens E no rank Decreases
0 1 Escherichia coli O1:K1:H7 no rank Decreases
0 1 Escherichia coli O139:H1 no rank Decreases
0 1 Escherichia coli O141:H4 no rank Decreases
0 1 Escherichia coli O145:H34 no rank Decreases
0 1 Escherichia coli O15:H12 no rank Decreases
0 1 Escherichia coli O155:H21 no rank Decreases
0 1 Escherichia coli O158:H23 no rank Decreases
0 1 Escherichia coli O16:H48 no rank Decreases
0 1 Escherichia coli O170:H18 no rank Decreases
0 1 Escherichia coli O18ac:H14 no rank Decreases
0 1 Escherichia coli O19:H7 no rank Decreases
0 1 Escherichia coli O2:K1:H4 no rank Decreases
0 1 Escherichia coli O2:K1:H5 no rank Decreases
0 1 Escherichia coli O2:K1:H7 no rank Decreases
0 1 Escherichia coli O20:H12 no rank Decreases
0 1 Escherichia coli O25:H16 no rank Decreases
0 1 Escherichia coli O55:H7 no rank Decreases
0 1 Escherichia coli O68:H12 no rank Decreases
0 1 Escherichia coli O7:H15 no rank Decreases
0 1 Escherichia coli O78:H51 no rank Decreases
0 1 Escherichia coli O80:H26 no rank Decreases
0 1 Escherichia coli O84:H7 no rank Decreases
0 1 Escherichia coli O85:H1 no rank Decreases
0 1 Escherichia coli O103 serogroup Decreases
0 1 Escherichia coli O111 serogroup Decreases
0 1 Escherichia coli O119 serogroup Decreases
0 1 Escherichia coli O121 serogroup Decreases
0 1 Escherichia coli O145 serogroup Decreases
0 1 Escherichia coli O155 serogroup Decreases
0 1 Escherichia coli O157 serogroup Decreases
0 1 Escherichia coli O177 serogroup Decreases
0 1 Escherichia coli O26 serogroup Decreases
0 1 Escherichia coli O3 serogroup Decreases
0 1 Escherichia coli O43 serogroup Decreases
0 1 Escherichia coli O5 serogroup Decreases
0 1 Escherichia coli O78 serogroup Decreases
0 1 Escherichia coli O86 serogroup Decreases
0 1 Escherichia coli O91 serogroup Decreases
0 1 Escherichia coli H20 serotype Decreases
0 1 Escherichia coli O1:H42 serotype Decreases
0 1 Escherichia coli O1:HNT serotype Decreases
0 1 Escherichia coli O10:H32 serotype Decreases
0 1 Escherichia coli O10:K5(L):H4 serotype Decreases
0 1 Escherichia coli O100:H21 serotype Decreases
0 1 Escherichia coli O103:H11 serotype Decreases
0 1 Escherichia coli O103:H2 serotype Decreases
0 1 Escherichia coli O103:H25 serotype Decreases
0 1 Escherichia coli O104:H21 serotype Decreases
0 1 Escherichia coli O104:H4 serotype Decreases
0 1 Escherichia coli O111:H- serotype Decreases
0 1 Escherichia coli O111:H11 serotype Decreases
0 1 Escherichia coli O111:H8 serotype Decreases
0 1 Escherichia coli O111:NM serotype Decreases
0 1 Escherichia coli O112ab:H8 serotype Decreases
0 1 Escherichia coli O112ac:H19 serotype Decreases
0 1 Escherichia coli O113:H21 serotype Decreases
0 1 Escherichia coli O114:H49 serotype Decreases
0 1 Escherichia coli O118:H16 serotype Decreases
0 1 Escherichia coli O121:H19 serotype Decreases
0 1 Escherichia coli O121:H7 serotype Decreases
0 1 Escherichia coli O123:H11 serotype Decreases
0 1 Escherichia coli O125ac:K+:H10 serotype Decreases
0 1 Escherichia coli O126:H45 serotype Decreases
0 1 Escherichia coli O127:H27 serotype Decreases
0 1 Escherichia coli O127:H6 serotype Decreases
0 1 Escherichia coli O128:H2 serotype Decreases
0 1 Escherichia coli O128ac:H12 serotype Decreases
0 1 Escherichia coli O139:H28 serotype Decreases
0 1 Escherichia coli O145:H25 serotype Decreases
0 1 Escherichia coli O145:H28 serotype Decreases
0 1 Escherichia coli O145:NM serotype Decreases
0 1 Escherichia coli O146:H21 serotype Decreases
0 1 Escherichia coli O15:H18 serotype Decreases
0 1 Escherichia coli O150:H6 serotype Decreases
0 1 Escherichia coli O152:H23 serotype Decreases
0 1 Escherichia coli O153:H2 serotype Decreases
0 1 Escherichia coli O156:H25 serotype Decreases
0 1 Escherichia coli O157:H- serotype Decreases
0 1 Escherichia coli O157:H43 serotype Decreases
0 1 Escherichia coli O157:H7 serotype Decreases
0 1 Escherichia coli O157:NM serotype Decreases
0 1 Escherichia coli O16:H6 serotype Decreases
0 1 Escherichia coli O165:H25 serotype Decreases
0 1 Escherichia coli O167:H26 serotype Decreases
0 1 Escherichia coli O174:H2 serotype Decreases
0 1 Escherichia coli O174:H21 serotype Decreases
0 1 Escherichia coli O174:H8 serotype Decreases
0 1 Escherichia coli O176:H45 serotype Decreases
0 1 Escherichia coli O177:NM serotype Decreases
0 1 Escherichia coli O2:H6 serotype Decreases
0 1 Escherichia coli O2:K2:H1 serotype Decreases
0 1 Escherichia coli O25:H1 serotype Decreases
0 1 Escherichia coli O25:NM serotype Decreases
0 1 Escherichia coli O26:H1 serotype Decreases
0 1 Escherichia coli O26:H11 serotype Decreases
0 1 Escherichia coli O28ac:NM serotype Decreases
0 1 Escherichia coli O29:H4 serotype Decreases
0 1 Escherichia coli O32:H37 serotype Decreases
0 1 Escherichia coli O39:NM serotype Decreases
0 1 Escherichia coli O44:H18 serotype Decreases
0 1 Escherichia coli O45:H2 serotype Decreases
0 1 Escherichia coli O6:H16 serotype Decreases
0 1 Escherichia coli O6:H16:CFA/II serotype Decreases
0 1 Escherichia coli O6:K2:H1 serotype Decreases
0 1 Escherichia coli O69:H11 serotype Decreases
0 1 Escherichia coli O7:H4 serotype Decreases
0 1 Escherichia coli O7:K1 serotype Decreases
0 1 Escherichia coli O78:H12 serotype Decreases
0 1 Escherichia coli O78:H4 serotype Decreases
0 1 Escherichia coli O79:H7 serotype Decreases
0 1 Escherichia coli O8:H8 serotype Decreases
0 1 Escherichia coli O81:NM serotype Decreases
0 1 Escherichia coli O83:H1 serotype Decreases
0 1 Escherichia coli O86:H34 serotype Decreases
0 1 Escherichia coli O89m:H10 serotype Decreases
0 1 Escherichia coli O89m:H9 serotype Decreases
0 1 Escherichia coli O9:H10 serotype Decreases
0 1 Escherichia coli O91:H14 serotype Decreases
0 1 Escherichia coli O91:NM serotype Decreases
0 1 Escherichia coli O99:H6 serotype Decreases
0 1 Escherichia coli ONT:H33 serotype Decreases
1 0 Segatella copri species Decreases
1 0 Streptococcus salivarius species Decreases
1 0 Bacteroides xylanisolvens species Decreases
1 0 Coprococcus comes species Decreases
1 0 Escherichia coli species Decreases
1 0 Bacteroides caccae species Decreases
1 0 Bacteroides fragilis species Decreases
1 0 Bacteroides ovatus species Decreases
1 0 Bacteroides thetaiotaomicron species Decreases
1 0 Bacteroides uniformis species Decreases
1 0 Clostridioides difficile species Decreases
1 0 Clostridium perfringens species Decreases
1 0 Fusobacterium nucleatum species Decreases
1 0 Lacrimispora saccharolytica species Decreases
1 0 Mediterraneibacter gnavus species Decreases
1 0 Odoribacter splanchnicus species Decreases
1 0 Parabacteroides distasonis species Decreases
1 0 Parabacteroides merdae species Decreases
1 0 Streptococcus parasanguinis species Decreases
1 0 Lacticaseibacillus paracasei species Decreases
1 0 Thomasclavelia ramosa species Decreases
1 0 Bifidobacterium adolescentis species Decreases
1 0 Ruminococcus bromii species Decreases
2 0 Phocaeicola vulgatus species Decreases
1 0 Bilophila wadsworthia species Decreases
1 0 Blautia obeum species Decreases
1 0 Dorea formicigenerans species Decreases
1 0 [Ruminococcus] torques species Decreases
0 1 Phocaeicola vulgatus 274-1D4 strain Increases
0 1 Phocaeicola vulgatus ATCC 8482 strain Increases
0 1 Phocaeicola vulgatus CL09T03C04 strain Increases
0 1 Phocaeicola vulgatus dnLKV7 strain Increases
0 1 Phocaeicola vulgatus PC510 strain Increases
0 1 Phocaeicola vulgatus RJ2L3 strain Increases
0 1 Phocaeicola vulgatus str. 3775 SL(B) 10 (iv) strain Increases
0 1 Phocaeicola vulgatus str. 3775 SR(B) 19 strain Increases
0 1 Phocaeicola vulgatus str. 3975 RP4 strain Increases
0 1 Fusobacterium nucleatum subsp. nucleatum subspecies Decreases
0 1 Lacticaseibacillus paracasei subsp. paracasei subspecies Decreases
0 1 Lacticaseibacillus paracasei subsp. tolerans subspecies Decreases

Impact of meclofenamic acid sodium salt monohydrate,(prescription) on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Condition Positive Impact Negative Impact Benefit Ratio Impact
Abdominal Aortic Aneurysm 0.6 0.6
Acne 0.2 -0.2
ADHD 3.8 0.3 11.67
Age-Related Macular Degeneration and Glaucoma 0 0.5 0
Allergic Rhinitis (Hay Fever) 2.8 2.1 0.33
Allergies 3.9 3 0.3
Allergy to milk products 1.9 1.4 0.36
Alopecia (Hair Loss) 0.6 0.6
Alzheimer's disease 5.4 4 0.35
Amyotrophic lateral sclerosis (ALS) Motor Neuron 1.9 0.8 1.37
Ankylosing spondylitis 3.3 1.7 0.94
Anorexia Nervosa 1.6 2.5 -0.56
Antiphospholipid syndrome (APS) 1.6 0 0
Asthma 4.3 1.4 2.07
Atherosclerosis 2.5 1 1.5
Atrial fibrillation 2.6 2.1 0.24
Autism 6.9 6.7 0.03
Autoimmune Disease 0.9 0.5 0.8
Barrett esophagus cancer 0.5 0.4 0.25
benign prostatic hyperplasia 0.3 0.5 -0.67
Biofilm 2.8 2.8
Bipolar Disorder 1.8 0.5 2.6
Brain Trauma 0.6 0.8 -0.33
Breast Cancer 1.2 1.2
Cancer (General) 1 1.9 -0.9
Carcinoma 3.6 1.8 1
Celiac Disease 2.7 1.8 0.5
Cerebral Palsy 1.4 0.6 1.33
Chronic Fatigue Syndrome 5 4.2 0.19
Chronic Kidney Disease 3.1 0.4 6.75
Chronic Lyme 0.6 0.5 0.2
Chronic Obstructive Pulmonary Disease (COPD) 3.1 1.2 1.58
Chronic Urticaria (Hives) 1.7 1.3 0.31
Coagulation / Micro clot triggering bacteria 1.8 0.6 2
Cognitive Function 1.7 1.4 0.21
Colorectal Cancer 6.9 1.7 3.06
Constipation 1 0 0
Coronary artery disease 2.1 1.9 0.11
COVID-19 7.3 7.7 -0.05
Crohn's Disease 7.4 3.2 1.31
Cushing's Syndrome (hypercortisolism) 0.6 -0.6
cystic fibrosis 0.9 1 -0.11
d-lactic acidosis (one form of brain fog) 0.6 0.6
deep vein thrombosis 2.4 1 1.4
Denture Wearers Oral Shifts 1.7 1.7
Depression 8.3 4.3 0.93
Dermatomyositis 0.4 0.2 1
Eczema 2.2 2.5 -0.14
Endometriosis 2.8 1.6 0.75
Eosinophilic Esophagitis 0.5 0.4 0.25
Epilepsy 3.7 1.7 1.18
erectile dysfunction 1.6 0.2 7
Fibromyalgia 2 2.9 -0.45
Functional constipation / chronic idiopathic constipation 5.1 3.9 0.31
gallstone disease (gsd) 3.2 0.7 3.57
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus 1.8 0.4 3.5
Generalized anxiety disorder 3.2 1.7 0.88
giant cell arteritis 0.4 -0.4
Glioblastoma 0.4 -0.4
Gout 2.3 0.7 2.29
Graves' disease 1.3 1.2 0.08
Gulf War Syndrome 1.1 1.4 -0.27
Halitosis 2 0.4 4
Hashimoto's thyroiditis 1.9 0.7 1.71
Heart Failure 4.9 0.4 11.25
hemorrhagic stroke 1 1
Hidradenitis Suppurativa 1.4 1.4
High Histamine/low DAO 1.6 0.3 4.33
hypercholesterolemia (High Cholesterol) 1.5 1.5
hyperglycemia 1.6 1.1 0.45
Hyperlipidemia (High Blood Fats) 0.2 0.2
hypersomnia 0 0
hypertension (High Blood Pressure 2.7 3.6 -0.33
Hypothyroidism 0.5 -0.5
Hypoxia 3 0.2 14
IgA nephropathy (IgAN) 2 3.6 -0.8
Inflammatory Bowel Disease 8 6.1 0.31
Insomnia 1.9 1 0.9
Intelligence 2.3 0.7 2.29
Intracranial aneurysms 1.6 0.3 4.33
Irritable Bowel Syndrome 5.5 3.7 0.49
ischemic stroke 2.3 0.8 1.87
Liver Cirrhosis 5.6 3 0.87
Long COVID 5.7 3.9 0.46
Low bone mineral density 0.3 -0.3
Lung Cancer 0.9 0.2 3.5
Lymphoma 0.3 0.3
Mast Cell Issues / mastitis 1.3 0.6 1.17
ME/CFS with IBS 0.8 1.3 -0.63
ME/CFS without IBS 1.4 1.3 0.08
membranous nephropathy 0.4 0.4
Menopause 1.3 1.3
Metabolic Syndrome 6.2 5.1 0.22
Mood Disorders 8 4.3 0.86
multiple chemical sensitivity [MCS] 1.1 0 0
Multiple Sclerosis 4.4 4.9 -0.11
Multiple system atrophy (MSA) 0.6 0.4 0.5
myasthenia gravis 0.7 0.4 0.75
neuropathic pain 1.6 -1.6
Neuropathy (all types) 0.4 1.4 -2.5
neuropsychiatric disorders (PANDAS, PANS) 1.5 1.5
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 5 2 1.5
NonCeliac Gluten Sensitivity 0.7 0.6 0.17
Obesity 6.9 6.5 0.06
obsessive-compulsive disorder 5.1 3.2 0.59
Osteoarthritis 3.1 1.2 1.58
Osteoporosis 1.3 0.9 0.44
pancreatic cancer 1.5 0.4 2.75
Parkinson's Disease 5.9 4.9 0.2
Polycystic ovary syndrome 6.1 2.4 1.54
Postural orthostatic tachycardia syndrome 0.4 0.5 -0.25
Premenstrual dysphoric disorder 0.2 0.5 -1.5
primary biliary cholangitis 0.4 1.9 -3.75
Primary sclerosing cholangitis 2.8 2.6 0.08
Psoriasis 2.4 2.5 -0.04
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 4.6 2.9 0.59
Rosacea 0.4 0.4 0
Schizophrenia 4.9 2 1.45
scoliosis 0.9 0.2 3.5
Sjögren syndrome 2.4 2.1 0.14
Sleep Apnea 1.2 0.8 0.5
Slow gastric motility / Gastroparesis 1.2 0.2 5
Small Intestinal Bacterial Overgrowth (SIBO) 2.6 2.6
Stress / posttraumatic stress disorder 2.6 1.4 0.86
Systemic Lupus Erythematosus 4.6 1.4 2.29
Tic Disorder 1.2 0.9 0.33
Tourette syndrome 0.4 0.5 -0.25
Type 1 Diabetes 3.4 2 0.7
Type 2 Diabetes 6 5.9 0.02
Ulcerative colitis 5.3 6.3 -0.19
Unhealthy Ageing 4.2 1.5 1.8
Vitiligo 2.3 1.6 0.44

Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.

Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served.   Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA   Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.   Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.   Inventions /Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]